The lack of effective treatments for Alzheimer’s have spurred scientists to rethink the dominant approach to tackling the disease: the amyloid hypothesis. This hypothesis…
Nearly two full years into the COVID-19 pandemic, researchers are still in the process of learning what’s really going on inside the heads of…
Scientists have their eyes set on spotting Alzheimer’s early. The earlier the disease can be diagnosed, the better the chance that a combination of…
Diagnosing degenerative brain diseases early and accurately is a major challenge, and it can take years before a patient receives an accurate diagnosis. But…
Scientists are looking toward microglia cells as therapeutic targets for Alzheimer’s. Microglia, known as the janitors of our brains, are responsible for clearing harmful…
Scientists in the field of Alzheimer’s have struggled to carry promising findings in mice studies into human trials, but primate researchers believe that animals…
In the 1990s, the idea that clumps of beta-amyloid proteins are the main culprits of Alzheimer’s took off, and this line of thought —…
What if the reason we can’t seem to crack the code on how to prevent, treat, or even fully understand Alzheimer’s disease is that……
This article was produced by Being Patient in partnership with Charter Research. More information on Alzheimer’s clinical trials can be found on the Charter…
Benjamin Stecher was diagnosed with Parkinson’s disease at the age of 29. He has since become actively involved in Parkinson’s disease research and advocacy….
Alzheimer’s main hallmarks — beta-amyloid plaques and tau tangles — have long been the focus of the quest to come up with an Alzheimer’s…
Increasingly, scientists have looked to the eye for clues to Alzheimer’s. Past studies have taken all angles, from identifying links between beta-amyloid clumps in…
The toxic accumulation of four abnormal proteins in the brain is such a harbinger of cognitive decline, one researcher has taken to calling them…
A new study published in International Journal of Molecular Sciences (IJMS) links certain enzymes with degenerative brain diseases, which could mean scientists and drugmakers now…
Currently, Alzheimer’s disease and other dementias are typically detected and diagnosed through memory and cognitive tests or MRI and PET scans of the brain,…